AvevoRx Reaffirms Commitment to Alpha-1 Antitrypsin (AAT) Deficiency Patients with Investments in Advocacy and Disease Management Services

Company aims to help fill critical nationwide gaps in Alpha-1 proteinase inhibitor treatment support as it marks its one-year entry into the market GREENSBORO, N.C., Dec. 18, 2023 /PRNewswire-PRWeb/ -- AvevoRx, a national, independent provider of specialty infusion pharmacy services, has...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news